At interim analysis, giredestrant demonstrated a statistically significant and clinically meaningful benefit versus standard-of-care endocrine monotherapyThese unprecedented results support its…
FOSTER CITY, Calif., Nov. 17, 2025 (GLOBE NEWSWIRE) -- Apollomics Inc. (Nasdaq: APLM) (“Apollomics” or the “Company”), a California-based late-stage…
Certification opens the United Kingdom market for the first FDA-cleared AI platform for prostate MRI interpretation. OMAHA, Neb., Nov. 18,…
Proprietary agentic AI model transforms genomic and real-world data into actionable insights across the full drug lifecycle Enables faster development of…
ARLINGTON, VIRGINIA / ACCESS Newswire / November 17, 2025 / The American Association of Medical Assistants® (AAMA) installed Sherry Bogar,…
ORLANDO, FLORIDA / ACCESS Newswire / November 17, 2025 / Exousia Pro, Inc. (OTCID:MAJI), a clinical-stage biotechnology company focused on…
LED operating light market is experiencing robust expansion driven by rising procedural volumes, growing adoption of minimally invasive surgery, and…
DURHAM, N.C. and SEOUL, South Korea, Nov. 17, 2025 /PRNewswire/ -- Lunit, a leading provider of AI for cancer diagnostics…
New deep learning system integrates images and clinical details, improving early skin cancer diagnosis and aiding in smart healthcare INCHEON,…
SAN FRANCISCO, Nov. 17, 2025 /PRNewswire/ -- On July 24, 2025 a life-saving event unfolded when a trained citizen volunteer…